D M Castro-Díaz1, M Esteban-Fuertes2, J Salinas-Casado3, S Bustamante-Alarma4, J L Gago-Ramos5, A Galacho-Bech6, M J García-Matres7, L A Rodríguez-Toves8, C Zubiaur-Líbano9, A Collado-Serra10, J E Batista-Miranda11, A Ortiz-Gámiz12. 1. Servicio de Urología, Hospital Universitario de Canarias, Universidad de La Laguna, San Cristóbal de la Laguna, Tenerife, España. Electronic address: davidcastro@teide.net. 2. Servicio de Urología, Hospital de Parapléjicos, Toledo, España. 3. Servicio de Urología, Hospital Clínico San Carlos, Madrid, España. 4. Servicio de Urología, Hospital Universitario Puerta del Hierro, Madrid, España. 5. Servicio de Urología, Hospital Germans Trias i Pujol, Badalona, Barcelona, España. 6. Unidad de Gestión Clínica de Urología, Hospital Virgen de la Victoria, Málaga, España. 7. Servicio de Urología, Hospital Universitario La Paz, Madrid, España. 8. Servicio de Urología, Hospital Río Hortega, Valladolid, España. 9. Servicio de Urología, Hospital de Basurto, Bilbao, España. 10. Servicio de Urología, Instituto Valenciano de Oncología (IVO), Valencia, España. 11. Servicio de Urología, Centro Médico Teknon, Barcelona, España. 12. Servicio de Urología, Hospital Virgen de la Macarena, Sevilla, España.
Abstract
OBJECTIVES: To evaluate the psychometric properties of the Spanish version of the ICIQ-Male Lower Urinary Tract Symptoms Questionnaire (ICIQ-MLUTS): Feasibility (% of completion and ceiling/ground effects), reliability (Test-retest), convergent validity (vs Bladder Control Self-Assessment Questionnaire [BSAQ] and vs International Prostate Symptom Score [I-PSS]) and criterion validity (according to presence or absence of symptoms). MATERIAL AND METHODS: This was an observational, non-interventionist and multicenter study. 223 male patients with lower urinary tract symptoms (LUTS), predominantly storage symptoms and aged 18-65, took part in the study. Patients completed the ICIQ-MLUTS (test), I-PSS and BSAQ questionnaires and referred their urinary symptoms in a single visit, with the exception of a subgroup composed by 49 patients that completed the questionnaire again 15 days after initial visit to evaluate test-retest reliability. The questionnaire includes 13 items divided in 2 sub-scales: Voiding symptoms (V) from 0-20 and Incontinence symptoms (I) from 0-24. RESULTS: Percentage of patients that completed all items: 98.84%. Ground effect is 0 and ceiling effect was under 6% in both sub-scales. Test-retest reliability: Intraclass correlation coefficient (ICC) ranged from 0.68 to 0.88, except on Delay. Kappa shows a good agreement, between 0.60 and 0.81, except for Nocturia. Convergent validity: Correlation (Spearman) between the questionnaire sub-scales scores and the rest of measures is statistically significant (P < .01 and P < .05). Criterion validity: Statistically significant differences (P < .05) between scores on ICIQ-MLUTS, from patients that refer experiencing symptoms and those who do not. CONCLUSION: The Spanish version of the ICIQ-MLUTS questionnaire shows adequate feasibility, reliability and validity.
OBJECTIVES: To evaluate the psychometric properties of the Spanish version of the ICIQ-Male Lower Urinary Tract Symptoms Questionnaire (ICIQ-MLUTS): Feasibility (% of completion and ceiling/ground effects), reliability (Test-retest), convergent validity (vs Bladder Control Self-Assessment Questionnaire [BSAQ] and vs International Prostate Symptom Score [I-PSS]) and criterion validity (according to presence or absence of symptoms). MATERIAL AND METHODS: This was an observational, non-interventionist and multicenter study. 223 male patients with lower urinary tract symptoms (LUTS), predominantly storage symptoms and aged 18-65, took part in the study. Patients completed the ICIQ-MLUTS (test), I-PSS and BSAQ questionnaires and referred their urinary symptoms in a single visit, with the exception of a subgroup composed by 49 patients that completed the questionnaire again 15 days after initial visit to evaluate test-retest reliability. The questionnaire includes 13 items divided in 2 sub-scales: Voiding symptoms (V) from 0-20 and Incontinence symptoms (I) from 0-24. RESULTS: Percentage of patients that completed all items: 98.84%. Ground effect is 0 and ceiling effect was under 6% in both sub-scales. Test-retest reliability: Intraclass correlation coefficient (ICC) ranged from 0.68 to 0.88, except on Delay. Kappa shows a good agreement, between 0.60 and 0.81, except for Nocturia. Convergent validity: Correlation (Spearman) between the questionnaire sub-scales scores and the rest of measures is statistically significant (P < .01 and P < .05). Criterion validity: Statistically significant differences (P < .05) between scores on ICIQ-MLUTS, from patients that refer experiencing symptoms and those who do not. CONCLUSION: The Spanish version of the ICIQ-MLUTS questionnaire shows adequate feasibility, reliability and validity.
Authors: Anne Pavy-Le Traon; Nikki Cotterill; Gerard Amarenco; Susanne Duerr; Horacio Kaufmann; Heinz Lahrmann; François Tison; Gregor K Wenning; Christopher G Goetz; Werner Poewe; Cristina Sampaio; Anette Schrag; Olivier Rascol; Pablo Martinez-Martin; Glenn T Stebbins Journal: Mov Disord Clin Pract Date: 2018-10-25
Authors: Antonio Tienza; Petra L Graham; Jose E Robles; Fernando Diez-Caballero; David Rosell; Juan I Pascual; Manish I Patel; Sean F Mungovan Journal: Int Neurourol J Date: 2020-06-30 Impact factor: 2.835